1. PAI‐1 gain‐of‐function genotype, factors increasing PAI‐1 levels, and airway obstruction: The GALA II Cohort
- Author
-
Sherenian, MG, Cho, SH, Levin, A, Min, J‐Y, Oh, SS, Hu, D, Galanter, J, Sen, S, Huntsman, S, Eng, C, Rodriguez‐Santana, JR, Serebrisky, D, Avila, PC, Kalhan, R, Smith, LJ, Borrell, LN, Seibold, MA, Williams, L Keoki, Burchard, EG, and Kumar, R
- Subjects
Biomedical and Clinical Sciences ,Immunology ,Lung ,Genetics ,Prevention ,Clinical Research ,Asthma ,Aetiology ,2.1 Biological and endogenous factors ,Respiratory ,Adolescent ,Adult ,Airway Obstruction ,Alleles ,Asthma ,Occupational ,Child ,Cohort Studies ,Ethnicity ,Female ,Gain of Function Mutation ,Genetic Association Studies ,Genetic Predisposition to Disease ,Genotype ,Humans ,Male ,Odds Ratio ,Plasminogen Activator Inhibitor 1 ,Polymorphism ,Single Nucleotide ,Respiratory Function Tests ,Young Adult ,asthma ,epidemiology ,PAI-1 ,pediatrics ,Nutrition and Dietetics ,Public Health and Health Services ,Allergy - Abstract
BackgroundPAI-1 gain-of-function variants promote airway fibrosis and are associated with asthma and with worse lung function in subjects with asthma.ObjectiveWe sought to determine whether the association of a gain-of-function polymorphism in plasminogen activator inhibitor-1 (PAI-1) with airway obstruction is modified by asthma status, and whether any genotype effect persists after accounting for common exposures that increase PAI-1 level.MethodsWe studied 2070 Latino children (8-21y) with genotypic and pulmonary function data from the GALA II cohort. We estimated the relationship of the PAI-1 risk allele with FEV1/FVC by multivariate linear regression, stratified by asthma status. We examined the association of the polymorphism with asthma and airway obstruction within asthmatics via multivariate logistic regression. We replicated associations in the SAPPHIRE cohort of African Americans (n=1056). Secondary analysis included the effect of the at-risk polymorphism on postbronchodilator lung function.ResultsThere was an interaction between asthma status and the PAI-1 polymorphism on FEV1 /FVC (P=.03). The gain-of-function variants, genotypes (AA/AG), were associated with lower FEV1 /FVC in subjects with asthma (β=-1.25, CI: -2.14,-0.35, P=.006), but not in controls. Subjects with asthma and the AA/AG genotypes had a 5% decrease in FEV1 /FVC (P
- Published
- 2017